What is Stryker's SG&A?

Stryker (SYK) reported SG&A of $2.28B in Q1 2026.

How has Stryker's SG&A changed year-over-year?

Stryker's SG&A decreased by 0.8% year-over-year, from $2.3B to $2.28B.

What is the long-term trend for Stryker's SG&A?

Over 4 years (2021 to 2025), Stryker's SG&A has grown at a 7.7% compound annual growth rate (CAGR), from $6.43B to $8.65B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Stryker SYK SG&A

SG&A at other companies

Baxter InternationalBAX

$728M+3.6%

Johnson & JohnsonJNJ

$6.03B+18.0%

CONMEDCNMD

$141.7M-4.8%

Merit Medical SystemsMMSI

$118.21M+10.0%

Orthofix Medical Inc.OFIX

$134.91M+1.5%

Boston ScientificBSX

$1.78B+11.5%

Segments

By segment

See full

MedSurg and Neurotechnology:$930M+8.3%

Orthopaedics$925M—

Other financials

Income statement

See full

Revenue$6.0B+2.6%

Gross profit$3.8B+1.8%

Operating income$936.0M+11.8%

Net income$745.0M+13.9%

EPS (diluted)$1.93+14.2%

Balance sheet

See full

Cash & equivalents$2.9B+24.1%

Total debt$14.4B-15.1%

Total assets$46.3B+0.6%

Cash flow

See full

Operating cash flow$581.0M+132%

CapEx$166.0M+35.0%

Free cash flow$415.0M+227%

Valuation

See full

Market cap$121.18B-15.6%

Enterprise value$132.69B-16.1%

P/E36.3×-13.9×

P/S4.8×-1.4×

Profitability

See full

Gross margin63.8%-0.1pp

Operating margin19.7%+4.4pp

Net margin13.2%+0.9pp

FCF margin18.1%+2.7pp

Returns & leverage

See full

Return on equity32.8%—

Debt / equity0.8×—

Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stryker's SG&A?: Stryker (SYK) reported SG&A of $2.28B in Q1 2026.
How has Stryker's SG&A changed year-over-year?: Stryker's SG&A decreased by 0.8% year-over-year, from $2.3B to $2.28B.
What is the long-term trend for Stryker's SG&A?: Over 4 years (2021 to 2025), Stryker's SG&A has grown at a 7.7% compound annual growth rate (CAGR), from $6.43B to $8.65B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.